For a limited time, patients with a prescription can get a steep discount on the popular medications, as long as they’re ...
Signs of a weight loss price war appeared to worry investors early Monday, and Lilly and Novo stocks were down.
Dow Jones Top Company Headlines at 3 PM ET: Novo Nordisk Cuts Prices for Obesity Drugs | What ... The Denmark-based company slashed prices for the first two monthly doses of Wegovy and Ozempic for ...
Novo Nordisk said on Monday it would lower the U.S. price of its injectable Wegovy obesity drug and pledged to go "all in" on ...
Novo Nordisk offers Ozempic Wegovy sold 199 per month for new self-paying patients from Nov. 17 to March 31 with discounted initial doses.
Novo Nordisk is chopping prices again for Wegovy, but doctors say the expense will remain challenging for patients without insurance.
The cash price of the popular weight-loss drug Wegovy was lowered by 30% on Monday, now priced at $349, down from $499.
Novo Holdings A/S, a vehicle for the Novo Nordisk Foundation, is set to exit its remaining position in medical technology ...
Novo Holdings will sell its stake of around 7.8% in medical-device maker Convatec.
The drugs have become popular for their significant weight-loss effects, but their high cost has made them inaccessible for ...
Novo Nordisk offers limited-time $199 pricing on Wegovy and Ozempic, lowers self-pay costs, and prepares for a stronger ...
A conservative group led by Mike Pence allies opposes Trump's Most-Favored-Nation drug pricing agreements with Eli Lilly and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results